Powered by

Arvelle Announces Closing of Final Tranche of Series A Financing Round

May 26, 2020 - Thomson Reuters ONE
Investments

Arvelle Announces Closing of Final Tranche of Series A Financing Round

Brings the total financing to $207.8m

Triggered by successful filing and validation of the MAA for cenobamate

Zug, Switzerland, 26 May 2020 - Arvelle Therapeutics, an emerging biopharmaceutical company focused on bringing innovative treatments to patients suffering from CNS disorders, is pleased to announce that the Company has closed the final tranche of its Series A financing round. The final tranche was t...